ClearLight Closes Lab Services and Offers Expert Consulting Services Learn More

ClearLight will be at Immuno-Oncology 360° 2021, happening February 23-26, 2021!

Posted on Feb 02, 2021

We are excited to connect with our colleagues in the immuno-oncology field.

ClearLight’s CLARITY Tissue Clearing and 3D IHC are key technologies for cutting edge cancer research. CLARITY and 3D IHC allow researchers to enter the tumor microenvironment like never before. ClearLight is here to support pre-clinical cancer researchers to move the field of immuno-oncology forward.

Sharla White, our V.P. of Research and Development, is a contributor to the award-winning research paper Three-dimensional Imaging and Quantitative Analysis in CLARITY Processed Breast Cancer Tissues. This paper helps demonstrate the relevance of ClearLight’s technology to the field of cancer research.

Will you be at Immuno-Oncology 360° 2021? We’d love to talk with you!

Immuno-Oncology 360° 2021





Analysis can be performed for select biomarkers, please contact us to find out if your target of interest is one of them. Imaging is currently performed on select fields of view instead of the entire sample.

Submission Guidelines

Tissue Sample Requirements: